• Skip to main content

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

News

News

SK Capital Partners / February 1, 2022

Feb 01, 2022 / SK Capital

SK Capital Announces Anne Kolton as Chief Sustainability Officer

Newly created position demonstrates continued leadership in sustainability New York, February 1, 2022 – SK Capital Partners, LP (“SK Capital”), a private …

➞

SK Capital Partners / January 31, 2022

Jan 31, 2022 / SK Capital

Science History Institute Names SK Capital’s Barry Siadat 2022 Bolte Award Winner

Noted academic and entrepreneur to be recognized as part of the Institute’s annual Heritage Day celebration on May 11, 2022. The Science History Institute is …

➞

SK Capital Partners / January 11, 2022

Jan 11, 2022 / SK Capital

SK Capital Announces Promotions

‌New York, January 10, 2022 – SK Capital Partners, LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, is …

➞

SK Capital Partners / January 5, 2022

Jan 05, 2022 / Tilley

Tilley-Phoenix Group Completes the Acquisition of Callahan Chemical

Tilley-Phoenix Group is pleased to announce the addition of Callahan Chemical Company to expand its product portfolio and geographic reach Palmyra, New …

➞

SK Capital Partners / January 3, 2022

Jan 03, 2022 / Heubach

The Heubach Group and SK Capital Partners Close Acquisition of Global Colorants Business of Clariant and Announce Appointment of Stefan Doboczky as Chief Executive Officer

Langelsheim, Germany / New York, NY, January 3, 2022 – The Heubach Group (“Heubach”, the “Company”), a leading global producer of pigments and SK Capital …

➞

SK Capital Partners / December 17, 2021

Dec 17, 2021 / Seqens, SK Capital

SK CAPITAL PARTNERS ACQUIRES MAJORITY SHAREHOLDING OF SEQENS, A LEADER IN PHARMACEUTICALS AND SPECIALTY INGREDIENTS

NEW YORK, December 16, 2021 – Funds advised by SK Capital Partners (“SK Capital”), a private investment firm focused on the specialty materials, chemicals and …

➞

  • ➞
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 22
  • ➞

© 2022 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login